Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study
- Citation:
- Cancer Res vol 75 (9 Supplement) abstr OT2-1-04
- Meeting Instance:
- SABCS 2014
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- This research was also supported in part by grants from the Breast Cancer Research Foundation, Genentech, and the Investigator-Sponsored Study Program of AstraZeneca
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None